3.9 Article

ERα Phosphorylation at Y537 by Src Triggers E6-AP-ERα Binding, ERα Ubiquitylation, Promoter Occupancy, and Target Gene Expression

期刊

MOLECULAR ENDOCRINOLOGY
卷 26, 期 9, 页码 1567-1577

出版社

OXFORD UNIV PRESS INC
DOI: 10.1210/me.2012-1140

关键词

-

资金

  1. National Institutes of Health [NCI 5 R01 CA 123415-04]

向作者/读者索取更多资源

Many transcription factors undergo transcription-coupled proteolysis. Although ligand binding activates ubiquitin proteolysis of estrogen receptor alpha (ER alpha), mechanisms governing this and its relationship to transcriptional activation were unclear. Data presented link cross talk between the Src kinase and liganded ER alpha with ER alpha activation and its ubiquitylation. Liganded ER alpha rapidly activates and recruits Src, which phosphorylates ER alpha at tyrosine 537 (Y537). This enhances ER alpha binding to the ubiquitin ligase/ER alpha coactivator, E6-associated protein (E6-AP), stimulating ER alpha ubiquitylation, target gene activation, and ultimately ER alpha loss. ER alpha phosphorylation by Src promotes ER alpha ubiquitylation by E6-AP and proteasomal degradation in vitro. Src inhibition impairs estrogen (E2)-activated ER alpha:E6-AP binding, reducing ER alpha degradation. ER alpha-Y537F shows little E2-stimulated degradation and activates native ER alpha target genes poorly. Src activation enhances ER alpha and E6-AP binding and their occupancy at ER alpha target gene promoters to enhance transcription. Thus, ER alpha Y537 phosphorylation drives ER alpha:E6-AP binding to at least a subset of target promoters, linking transcriptional activation to ER alpha degradation and providing a novel mechanism to fine tune ER alpha action. The observation that ER alpha transcriptional activity can be briskly maintained in a context of reduced ER alpha levels raises the possibility that hormonally sensitive tissues may not always show robust ER alpha protein levels. (Molecular Endocrinology 26: 1567-1577, 2012)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.9
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell Biology

Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells

Neil T. Pfister, Vitalay Fomin, Kausik Regunath, Jeffrey Y. Zhou, Wen Zhou, Laxmi Silwal-Pandit, William A. Freed-Pastor, Oleg Laptenko, Suat Peng Neo, Jill Bargonetti, Mainul Hoque Bin Tian, Jayantha Gunaratne, Olav Engebraaten, James L. Manley, Anne-Lise Borresen-Dale, Paul M. Neilsen, Carol Prives

GENES & DEVELOPMENT (2015)

Article Biochemistry & Molecular Biology

Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation

D. Zhao, A. H. Besser, S. A. Wander, J. Sun, W. Zhou, B. Wang, T. Ince, M. A. Durante, W. Guo, G. Mills, D. Theodorescu, J. Slingerland

ONCOGENE (2015)

Review Endocrinology & Metabolism

The emerging regulation of veGFR-2 in triple-negative breast cancer

Xiaoxia Zhu, Wen Zhou

FRONTIERS IN ENDOCRINOLOGY (2015)

Editorial Material Endocrinology & Metabolism

Transcriptional Regulation in Cancers and Metabolic Diseases

Wen Zhou

FRONTIERS IN ENDOCRINOLOGY (2015)

Article Oncology

Notch Represses Transcription by PRC2 Recruitment to the Ternary Complex

Xiaoqing Han, Prathibha Ranganathan, Christos Tzimas, Kelly L. Weaver, Ke Jin, Luisana Astudillo, Wen Zhou, Xiaoxia Zhu, Bin Li, David J. Robbins, Anthony J. Capobianco

MOLECULAR CANCER RESEARCH (2017)

Meeting Abstract Oncology

Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor progression via Twist1 upregulation

Dekuang Zhao, Alexandra H. Besser, Wen Zhou, Seth A. Wander, Jun Sun, Michael Durante, Feng Hong, Bin Wang, Tan Ince, Karoline Briegel, Joyce M. Slingerland

CANCER RESEARCH (2014)

Article Genetics & Heredity

The HDAC inhibitor depsipeptide transactivates the p53/p21 pathway by inducing DNA damage

Haiying Wang, Wen Zhou, Zhixing Zheng, Ping Zhang, Bo Tu, Qihua He, Wei-Guo Zhu

DNA REPAIR (2012)

Article Biochemistry & Molecular Biology

ERα, SKP2 and E2F-1 form a feed forward loop driving late ERα targets and G1 cell cycle progression

W. Zhou, S. Srinivasan, Z. Nawaz, J. M. Slingerland

ONCOGENE (2014)

Article Cell Biology

GLI1 activation by non-classical pathway integrin αvβ3/ERK1/2 maintains stem cell-like phenotype of multicellular aggregates in gastric cancer peritoneal metastasis

Hui Dong, Hongchang Liu, Wen Zhou, Fan Zhang, Chuan Li, Jun Chen, Chenjun Tan, Bo Tang, Peiwu Yu

CELL DEATH & DISEASE (2019)

Article Oncology

p53 Frameshift Mutations Couple Loss-of-Function with Unique Neomorphic Activities

David R. Tong, Wen Zhou, Chen Katz, Kausik Regunath, Divya Venkatesh, Chinyere Ihuegbu, James J. Manfredi, Oleg Laptenko, Carol Prives

Summary: p53 mutations commonly lead to loss of transcriptional activity in cancer, with some variants retaining DNA-binding domains but losing transcriptional activity, and resulting in C-terminally truncated proteins.

MOLECULAR CANCER RESEARCH (2021)

Editorial Material Endocrinology & Metabolism

Editorial: Immune checkpoint inhibitors in cancer: balancing the benefits with the side effects?

Cristiane J. Gomes-Lima, Wen Zhou, Zoe Quandt

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Oncology

Acetylation of Mastermind-like 1 by p300 Drives the Recruitment of NACK to Initiate Notch-Dependent Transcription

Ke Jin, Wen Zhou, Xiaoqing Han, Zhiqiang Wang, Bin Li, Shawn Jeffries, Wensi Tao, David J. Robbins, Anthony J. Capobianco

CANCER RESEARCH (2017)

暂无数据